Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Venous Disease: Features

Review
Filter Considerations and Techniques for Challenging Retrievals
12/14/2022
The aim of this article is to review and describe the technical factors that may lead to filter retrieval failure, and to describe advanced techniques that may be utilized to retrieve these complex IVC filters.
The aim of this article is to review and describe the technical factors that may lead to filter retrieval failure, and to describe advanced techniques that may be utilized to retrieve these complex IVC filters.
The aim of this article is to...
12/14/2022
Vascular Disease Management
Acute Venous Intervention
The Use of the Aspirex™ Thrombectomy System for Iliofemoral Deep Vein Thrombosis
12/01/2022
I think the greatest advantage of the Aspirex™ Thrombectomy System is its simplicity. You can just turn it on and aspirate the thrombus out. 
I think the greatest advantage of the Aspirex™ Thrombectomy System is its simplicity. You can just turn it on and aspirate the thrombus out. 
I think the greatest advantage...
12/01/2022
Cath Lab Digest
Venclose Maven
VIdeos
Venclose Maven: The Only 360° RF Solution for the Treatment of Incompetent Perforator Veins
11/10/2022
Learn about the Venclose Maven Perforator Catheter from BD Venous.
Learn about the Venclose Maven Perforator Catheter from BD Venous.
Learn about the Venclose Maven...
11/10/2022
Vascular Disease Management
Dr. Jonathan Paul of Flow Medical
Video
Flow Medical: Data-Driven Interventions for Pulmonary Embolism
10/13/2022
Watch as Dr. Osman Ahmed and Dr. Jonathan Paul discuss Flow Medical as a company and what they are working on to improve outcomes in pulmonary embolism.
Watch as Dr. Osman Ahmed and Dr. Jonathan Paul discuss Flow Medical as a company and what they are working on to improve outcomes in pulmonary embolism.
Watch as Dr. Osman Ahmed and Dr....
10/13/2022
Vascular Disease Management
Dr Jonathan Paul and Dr Osman Ahmed of Flow Medical
Video
Flow Medical: Meet the Founders
10/13/2022
Meet the founders of Flow Medical, Interventional Cardiologist Jonathan Paul, MD, and Interventional Radiologist Osman Ahmed, MD.
Meet the founders of Flow Medical, Interventional Cardiologist Jonathan Paul, MD, and Interventional Radiologist Osman Ahmed, MD.
Meet the founders of Flow...
10/13/2022
Vascular Disease Management
Dr. Osman Ahmed of Flow Medical
Video
Flow Medical: Where Is the Science and Data for PE Interventions?
10/13/2022
Watch as Flow Medical founders Osman Ahmed, MD, and Jonathan Paul, MD, discuss the science behind the use of endovascular devices for PE interventions.
Watch as Flow Medical founders Osman Ahmed, MD, and Jonathan Paul, MD, discuss the science behind the use of endovascular devices for PE interventions.
Watch as Flow Medical founders...
10/13/2022
Vascular Disease Management
Dr. Gebauer
LINC 2022
DRAGON Investigates Double Venous Embolization
06/09/2022
Results from the DRAGON 1 trial were discussed on Tuesday, June 7,  by Bernhard Gebauer, MD, an interventional radiologist at the Charité University Hospital in Berlin, Germany.
Results from the DRAGON 1 trial were discussed on Tuesday, June 7,  by Bernhard Gebauer, MD, an interventional radiologist at the Charité University Hospital in Berlin, Germany.
Results from the DRAGON 1 trial...
06/09/2022
Vascular Disease Management
Primary Endpoint Outcomes
First-Time Data Release/LINC 2022
Abre 24-Month Study Outcomes and Subgroup Analyses
06/08/2022
Erin Murphy, MD, from Sanger Heart & Vascular Institute in Charlotte, North Carolina, shared the results of a study to evaluate the safety and effectiveness of the Abre venous self-expanding stent system (Medtronic) for treatment of...
Erin Murphy, MD, from Sanger Heart & Vascular Institute in Charlotte, North Carolina, shared the results of a study to evaluate the safety and effectiveness of the Abre venous self-expanding stent system (Medtronic) for treatment of...
Erin Murphy, MD, from Sanger...
06/08/2022
Vascular Disease Management
Dr. Paul Gagne
Video
Optimizing Outcomes for Patients With Deep and Superficial Venous Disease
02/22/2022
Dr. Paul Gagne discusses his presentation at ISET 2022.
Dr. Paul Gagne discusses his presentation at ISET 2022.
Dr. Paul Gagne discusses his...
02/22/2022
Vascular Disease Management
Case Report
Endovascular Recanalization of a Short-Segment Occlusion of the IVC Using Simultaneous Fluoroscopy and Ultrasound Guidance in a Patient With Budd-Chiari Syndrome and Chronic Kidney Disease (Stage 4): Technical Feasibility and Short-Term Outcomes
02/16/2022
This case report describes an endovascular technique in the management of symptomatic inferior vena cava occlusion in a patient with chronic kidney disease (stage 4) not on dialysis.
This case report describes an endovascular technique in the management of symptomatic inferior vena cava occlusion in a patient with chronic kidney disease (stage 4) not on dialysis.
This case report describes an...
02/16/2022
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement